PRENW

distress 2/10 · well-funded / low risk

$0.02+43%today-21% from 52w high

prenetics.com98 employeesFounded 2014Quarry Bay, Hong Kong

Revenue

$36M

Liquidity

$108M

Runway

5.0 yrs

Shares 1y

Price & events

-17.4% over 6M

CatalystRating changeDilutionFinancingdashed = today

+42.7%

-8.2%

-19.5%

—

-17.4%

All

Overview

Market Cap: $264.92K
Volume: 104.79K
52 Week Range: $0.01 – $0.02
Total Shares: 16.87M
Float Shares: 12.63M
RVOL: 7.56x
Beta: 0.25

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 16,874,089 · 2 offerings/1y · 0 PIPEs

2026-03-31F-3shelf_registration
2025-10-28424B5offering
2025-10-27424B5offering
2025-09-11EFFECTshelf_effective
2025-09-08F-3/Ashelf_registration
2025-08-22F-3/Ashelf_registration
2025-07-22F-3shelf_registration

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified